logologo
QuantliQuantli

Disc Medicine Inc

IRON

NASDAQ

Biotechnology

$78.84

USD

-1.17 (-1.46%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $3.07B

Volume 262.5K

Price Target

$85.00$120.00

USD

The 3 analysts offering 1-year price forecasts have a max estimate of $120.00 and a min estimate of $85.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$97.67

+$2.7 vs prior

Implied Upside

+23.9%

+3.4% vs prior

Analyst Covering

3

-4 vs prior period

Consensus

Buy

Unchanged vs prior

Signal Quality

Consensus Freshness

30%

Many ratings are older - consensus may be less current

Analyst Agreement

Low

Targets are widely dispersed - limited agreement on price

Mean vs Median

$9.67 Gap

Median $88.00 vs avg $97.67 - a few bullish outliers are pulling the average up

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

3 Buy

0 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

3

Hold

0

Sell

0

Strong Sell

0

3 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Douglas Tsao

HC Wainwright & Co.

Buy

Maintained

1 week ago

Plus
Plus
Plus

Sean Laaman

Morgan Stanley

Buy

Maintained

2 months ago

Plus
Plus
Plus

David Nierengarten

Wedbush

Buy

Reiterated

2 months ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

BEAM

Beam Therapeutics Inc

$26.75

+0.9%

GRAL

Grail Inc

$67.87

-0.5%

IOVA

Iovance Biotherapeutics Inc

$6.98

+7.1%

NRIX

Nurix Therapeutics Inc

$27.05

-0.5%

ARQT

Arcutis Biotherapeutics Inc

$26.19

+1.4%

CLDX

Celldex Therapeutics Inc

$41.95

-1.6%

IMNM

Immunome Inc

$27.20

+3.0%

IDYA

IDEAYA Biosciences Inc

$36.30

-1.0%

RARE

Ultragenyx Pharmaceutical Inc

$26.49

+0.4%